DRI
48
3
CAH
53
6
APH
67
3
URBN
42
4
XEL
69
2
OKE
81
3
KMI
69
2
LH
45
3
PVH
57
5
CVX
44
-2
WDC
43
2
EXC
56
2
AXP
69
3
CVS
50
2
CAT
62
7
ETN
79
4
HOG
33
4
AFL
49
3
AZO
48
2
NWL
50
6
DRI
48
3
CAH
53
6
APH
67
3
URBN
42
4
XEL
69
2
OKE
81
3
KMI
69
2
LH
45
3
PVH
57
5
CVX
44
-2
WDC
43
2
EXC
56
2
AXP
69
3
CVS
50
2
CAT
62
7
ETN
79
4
HOG
33
4
AFL
49
3
AZO
48
2
NWL
50
6
Financhill
Back

PROCEPT BioRobotics 10K Form

Sell
43

PRCT
PROCEPT BioRobotics

Last Price:
94.28
Seasonality Move:
-3.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $136.19M
Cash Flow: $-19.05M
Price / Cash Flow: 0
Annual Sales: $4.63
Price / Book: 21.19

Profitability

EPS (TTM): -1.95000
Net Income (TTM): $-100.06M
Gross Margin: $71.05M
Return on Equity: -37.42%
Return on Assets: -25.56%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRCT is 52.17%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 96.76% of Gross Profit Margin.
  • The Research & Development expenses have been 35.57% of Revenue.
  • The Interest Expense is -3.77% of Operating Income.
  • The Net Earning history of PRCT is -77.76% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 6.02
Quick Ratio: 4.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Sell
43
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy or a Sell?